These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 15387924)

  • 81. [Cirrhotic ascites; pathogenesis and therapeutic study].
    CACHERA R; DARNIS F
    Bull Med; 1954 Jan; 68(1):3-6. PubMed ID: 13141031
    [No Abstract]   [Full Text] [Related]  

  • 82. [Cirrhosis and its complications].
    Pelletier G
    Rev Prat; 2005 May; 55(10):1135-41. PubMed ID: 16097260
    [No Abstract]   [Full Text] [Related]  

  • 83. Natural history of chronic hepatitis B virus infection: what determines prognosis after cirrhotic decompensation?
    Wei L
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1631-2. PubMed ID: 19120855
    [No Abstract]   [Full Text] [Related]  

  • 84. Salt restriction in ascites with cirrhosis of liver: will enhanced salt restriction increase longevity?
    Desai HG
    J Assoc Physicians India; 2006 Jun; 54():504. PubMed ID: 16909705
    [No Abstract]   [Full Text] [Related]  

  • 85. [Studies of diuresis caused by hydrochlorothiazide].
    CASSANO A; CONTI F; COSTA C; CORDOVA C
    Riforma Med; 1959 Jun; 73(24):665-9. PubMed ID: 13675691
    [No Abstract]   [Full Text] [Related]  

  • 86. Is albumin infusion necessary after large volume paracentesis?
    Cárdenas A; Ginès P; Runyon BA
    Liver Int; 2009 May; 29(5):636-40; discussion 640-1. PubMed ID: 19413666
    [No Abstract]   [Full Text] [Related]  

  • 87. Management of HCV-related end-stage liver disease in HIV-coinfected patients.
    Merchante N; Jiménez-Saenz M; Pineda JA
    AIDS Rev; 2007; 9(3):131-9. PubMed ID: 17982938
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [Therapeutic strategies for liver cirrhosis with bleeding from esophageal varices].
    Wang JY; Tu CT
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jun; 13(6):457. PubMed ID: 15975284
    [No Abstract]   [Full Text] [Related]  

  • 89. [Therapy refractory ascites: insertion of a tunneled long-term peritoneal catheter].
    Semmo N; Seuthe B; Thimme R; Graf KJ
    Dtsch Med Wochenschr; 2009 Oct; 134(41):2073-6. PubMed ID: 19802769
    [No Abstract]   [Full Text] [Related]  

  • 90. Intestinal permeability in cirrhotic patients with and without ascites.
    Kalaitzakis E; Johansson JE; Bjarnason I; Björnsson E
    Scand J Gastroenterol; 2006 Mar; 41(3):326-30. PubMed ID: 16497621
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Combined use of water immersion and frusemide in treatment of resistant ascites in liver cirrhosis.
    Fawthrop F; O'Hare JP; Millar N; Weston CF; Read AE
    J R Soc Med; 1987 Dec; 80(12):776-7. PubMed ID: 3430532
    [No Abstract]   [Full Text] [Related]  

  • 92. [Diaphragmatic relaxation caused by ascites in liver cirrhosis].
    Okuda K; Shimokawa Y
    Rinsho Hoshasen; 1970 Sep; 15(9):682-9. PubMed ID: 5201975
    [No Abstract]   [Full Text] [Related]  

  • 93. [Does liver cirrhosis cause clinically relevant, but reversible chronic heart failure?].
    Lenz K; Gegenhuber A; Kapral C; Wewalka F
    Z Gastroenterol; 2005 Oct; 43(10):1185-6. PubMed ID: 16220457
    [No Abstract]   [Full Text] [Related]  

  • 94. [Peritoneojugular shunt in question].
    Kammerer J; Vernisse B; Fouet P
    Gastroenterol Clin Biol; 1980 May; 4(5):387-8. PubMed ID: 7399208
    [No Abstract]   [Full Text] [Related]  

  • 95. [Auto-transfusion of ascitic fluid in liver cirrhosis].
    Policlinico Prat; 1957 Feb; 64(5):162-4. PubMed ID: 13419600
    [No Abstract]   [Full Text] [Related]  

  • 96. Norfloxacin and cisapride combination decreases the incidence of spontaneous bacterial peritonitis in cirrhotic ascites.
    Itha S; Sharma A; Bhatt G
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1634. PubMed ID: 16928235
    [No Abstract]   [Full Text] [Related]  

  • 97. Clinical characteristics and outcome of patients with cirrhosis and refractory ascites.
    Moreau R; Delègue P; Pessione F; Hillaire S; Durand F; Lebrec D; Valla DC
    Liver Int; 2004 Oct; 24(5):457-64. PubMed ID: 15482343
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [Managing the complications of cirrhosis].
    Deltenre P; Mathurin P; Barraud H; Bronowicki JP; Jacquet E; Puche P; Jaber S; Navarro F; Pageaux GP
    Rev Prat; 2005 Sep; 55(14):1555-63. PubMed ID: 16255297
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Creation of a transjugular intrahepatic portosystemic shunt with use of a preexisting portal-hepatic vein fistula as an alternative route.
    Hagspiel KD; Shih MC; Kanu J; Caldwell SH; Angle JF
    J Vasc Interv Radiol; 2005 Mar; 16(3):426-8. PubMed ID: 15758145
    [No Abstract]   [Full Text] [Related]  

  • 100. Lymphatic decompression therapy of "intractable" ascites.
    Steigmann F; Long D; Mejicano R
    Am J Gastroenterol; 1968 Jul; 50(1):47-54. PubMed ID: 5662507
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.